Business Description
Illumina Inc
NAICS : 621511
SIC : 8071
ISIN : US4523271090
Share Class Description:
ILMN: Ordinary SharesTotal Employee Number:
8,650Compare
Compare
Traded in other countries / regions
ILMN.USA0J8Z.UKILMN.MexicoI1LM34.BrazilILU.GermanyILMN.Austria1ILMN.ItalyILMN.Switzerland Index Membership
Russell 1000Russell 3000MSCI World IndexNASDAQ 100S&P 500NASDAQ 100 IPO Date
2000-07-28Description
Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (9% of 2024 sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.45 | |||||
Equity-to-Asset | 0.41 | |||||
Debt-to-Equity | 0.95 | |||||
Debt-to-EBITDA | 1.78 | |||||
Interest Coverage | 8.61 | |||||
Piotroski F-Score | 6/9 | |||||
Altman Z-Score | 5.82 | |||||
Beneish M-Score | -2.77 | |||||
WACC vs ROIC | ||||||
Growth Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -1.6 | |||||
3-Year EPS without NRI Growth Rate | 31.7 | |||||
3-Year FCF Growth Rate | 106.8 | |||||
3-Year Book Growth Rate | -24.7 | |||||
Future 3-5Y EPS without NRI Growth Rate Estimate Industry Rank | 12.21 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 5.83 |
Momentum Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 78.46 | |||||
9-Day RSI | 73.73 | |||||
14-Day RSI | 71.01 | |||||
3-1 Month Momentum % | 27.61 | |||||
6-1 Month Momentum % | 20.99 | |||||
12-1 Month Momentum % | 62 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 1.75 | |||||
Quick Ratio | 1.36 | |||||
Cash Ratio | 0.74 | |||||
Days Inventory | 141.43 | |||||
Days Sales Outstanding | 61.83 | |||||
Days Payable | 53.24 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | 1.1 | |||||
Shareholder Yield % | 3.08 |
Profitability Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 66.2 | |||||
Operating Margin % | 19.6 | |||||
Net Margin % | 19.42 | |||||
EBITDA Margin % | 32.55 | |||||
FCF Margin % | 22.17 | |||||
OCF Margin % | 25.68 | |||||
ROE % | 34.38 | |||||
ROA % | 13.48 | |||||
ROIC % | 14.83 | |||||
3-Year ROIIC % | -4.82 | |||||
ROC (Joel Greenblatt) % | 65.98 | |||||
ROCE % | 24.54 | |||||
Years of Profitability over Past 10-Year | 7 | |||||
Moat Score | 8 | |||||
Tariff Resilience Score | 4 |
GF Value Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 34.31 | |||||
Forward PE Ratio | 36.08 | |||||
PE Ratio without NRI | 37.51 | |||||
Price-to-Owner-Earnings | 31.97 | |||||
PS Ratio | 6.63 | |||||
PB Ratio | 10.72 | |||||
Price-to-Tangible-Book | 29.81 | |||||
Price-to-Free-Cash-Flow | 29.89 | |||||
Price-to-Operating-Cash-Flow | 25.81 | |||||
EV-to-EBIT | 25.81 | |||||
EV-to-Forward-EBIT | 29.19 | |||||
EV-to-EBITDA | 20.93 | |||||
EV-to-Forward-EBITDA | 23.85 | |||||
EV-to-Revenue | 6.81 | |||||
EV-to-Forward-Revenue | 6.57 | |||||
EV-to-FCF | 30.74 | |||||
Price-to-GF-Value | 1.46 | |||||
Price-to-Projected-FCF | 3.88 | |||||
Price-to-Median-PS-Value | 0.64 | |||||
Price-to-Graham-Number | 7.05 | |||||
Earnings Yield (Greenblatt) % | 3.87 | |||||
FCF Yield % | 3.41 | |||||
Forward Rate of Return (Yacktman) % | -2.23 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:ILMN
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Illumina Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 4,393 | ||
| EPS (TTM) ($) | 5.5 | ||
| Beta | 1.404 | ||
| 3-Year Sharpe Ratio | 0.03 | ||
| 3-Year Sortino Ratio | 0.05 | ||
| Volatility % | 43.55 | ||
| 14-Day RSI | 71.01 | ||
| 14-Day ATR ($) | 6.822518 | ||
| 20-Day SMA ($) | 168.7695 | ||
| 12-1 Month Momentum % | 62 | ||
| 52-Week Range ($) | 88 - 189.46 | ||
| Shares Outstanding (Mil) | 151.3 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Illumina Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Illumina Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| Third quarter earnings conference call for 2026 | 2026-10-30 16:30 | In 119 days | ||
| Third quarter earnings results for 2026 | 2026-10-30 | In 118 days | ||
| Second quarter earnings conference call for 2026 | 2026-07-31 16:30 | In 28 days | ||
| Second quarter earnings results for 2026 | 2026-07-31 | In 27 days | ||
| General meeting for 2025 | 2026-05-21 10:00 | 141.92 (+0.11%) | ||
| First quarter earnings conference call for 2026 | 2026-04-30 16:30 | 120.37 (-4.39%) | ||
| First quarter earnings results for 2026 | 2026-04-30 | 120.37 (-4.39%) | ||
| TD Cowen 46th Annual Health Care Conference | 2026-03-03 12:10 | 132.89 (+0.87%) | ||
| Annual report for 2025 | 2026-02-12 | 116.38 (-1.61%) | ||
| Fourth quarter earnings conference call for 2025 | 2026-02-05 16:30 | 134.19 (-2.12%) |
Show
Entries
Illumina Inc Frequently Asked Questions
What is Illumina Inc(ILMN)'s stock price today?
The current price of ILMN is $188.68. The 52 week high of ILMN is $189.46 and 52 week low is $88.00.
When is next earnings date of Illumina Inc(ILMN)?
The next earnings date of Illumina Inc(ILMN) is 2026-07-31 Est..
Does Illumina Inc(ILMN) pay dividends? If so, how much?
Illumina Inc(ILMN) does not pay dividend.
Guru Commentaries on NAS:ILMN
No articles.
Press Release
Articles on Illumina Inc
No articles.
Headlines
See More- 1
Jun 13, 2026
Notable analyst calls this week: Pfizer, AMD and Intel among top picks
Seeking Alpha • 9:05am
Jun 10, 2026
Illumina raised to Overweight at J.P. Morgan after customer survey
Seeking Alpha • 11:48am
- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers